Centre Oscar Lambret

Neuro-oncology and Brain Tumors

The sponsor is involved in clinical research for glioblastoma, with interest in treatment intensification strategies for adults with newly diagnosed disease.

  • Glioblastoma
  • Temozolomide-based treatment approaches

Its activity in this area reflects a focus on aggressive central nervous system malignancies and treatment optimization in adult oncology.

Gynaecological Oncology

Clinical research also covers ovarian cancer, endometrial cancer, and cervical intraepithelial lesions, including surgical and locoregional management in women’s cancers.

  • Epithelial ovarian cancer
  • Fallopian tube and peritoneal ovarian cancer
  • Endometrial cancer
  • High-grade cervical intraepithelial lesions

The sponsor’s portfolio includes interest in hyperthermic intraperitoneal chemotherapy, surgical staging, and post-treatment HPV control in selected gynaecological settings.

Paediatric Solid Tumours

Another key area is paediatric oncology, with studies in relapsed or refractory solid tumours and Wilms tumor in children and teenagers.

  • Progressive or refractory paediatric solid tumours
  • Wilms tumor
  • Metronomic chemotherapy
  • Immune checkpoint inhibition

Research in this field includes treatment combinations for difficult-to-treat paediatric cancers and disease control in recurrent disease.

The sponsor funds studies in breast cancer, including fertility preservation for young women receiving systemic treatment and management of post-mastectomy pain syndrome.

  • Young women with breast cancer
  • Oocyte and embryo cryopreservation
  • Chronic neuropathic pain
  • Post-mastectomy syndrome

This area combines supportive care and reproductive health concerns linked to cancer treatment.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Early Temozolomide Treatment for Adults with Glioblastoma

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France
  • Study of Nivolumab with Chemotherapy for Children and Teenagers with Refractory or Relapsing Solid Tumors or Lymphoma

    Not recruiting

    1 1 1
    Investigated diseases:
    France